-
UPDATE: Jefferies & Company Reiterates Buy Rating, Raises PT for Amarin Corporation
Wednesday, June 27, 2012 - 8:49am | 98In a company note published earlier today, Jefferies & Company, Inc. reiterated its Buy rating for Amarin Corporation (NASDAQ: AMRN) and raised its price target from $24.00 to $26.00. Jefferies & Company went on to say “Yesterday, the patent office (PTO) posted unexpected positive office...
-
UPDATE: Jefferies & Company Reiterates Buy Rating, Lowers PT for Kosmos Energy
Monday, June 25, 2012 - 10:34am | 75In a report published earlier today, Jefferies & Company, Inc. reiterated its Buy rating for Kosmos Energy Ltd. (NYSE: KOS), but lowered its price target from $19.00 to $17.00. Jefferies went on to say “Kosmos Energy's exploration efforts outside of its core Ghana exposure is beginning to...
-
Jefferies & Company Reiterates Hold Rating, $91 PT for Philip Morris International
Monday, June 25, 2012 - 10:30am | 109In a report published earlier today, Jefferies & Company, Inc. reiterated its Hold rating and $91.00 price target for Philip Morris International (NYSE: PM). Jefferies went on to say “PM's analyst day presented a company that is aware of its short term challenges but very confident in its...
-
Jefferies & Company Reiterates Buy Rating, $39 PT for Tesla Motors
Monday, June 25, 2012 - 10:24am | 98In a report published earlier today, Jefferies & Company, Inc. reiterated its Buy rating and $39.00 price target for Tesla Motors, Inc. (NASDAQ: TSLA). Jefferies went on to say “If Apple made a car, this would be it. Our two behind the wheel test drives of the Model S confirmed our thesis that...
-
Jefferies & Company Reiterates Buy Rating, $62 PT for MICROS Systems
Monday, June 25, 2012 - 10:18am | 92In a report published earlier today, Jefferies & Company, Inc. reiterated its Buy rating and $62.00 price target for MICROS Systems, Inc. (NASDAQ: MCRS). Jefferies went on to say “We have updated our model to reflect the consolidation of Torex Retail, a weaker Euro and some slight moderation...
-
UPDATE: Jefferies & Company Reiterates Buy Rating, Lowers PT for Finish Line
Monday, June 25, 2012 - 10:14am | 121In a report published earlier today, Jefferies & Company, Inc. reiterated its Buy rating for Finish Line, Inc. (NASDAQ: FINL), but lowered its price target from $28.00 to $25.00. Jefferies went on to say “We expect 1Q earnings (Thursday 6/28 AM) to be an event despite the fact that the company...
-
UPDATE: Jefferies & Company Reiterates Buy Rating, Lowers PT for Nike
Monday, June 25, 2012 - 10:09am | 108In a report published earlier today, Jefferies & Company, Inc. reiterated its Buy rating for Nike, Inc. (NYSE: NKE), but lowered its price target from $130.00 to $115.00. Jefferies went on to say “We think a toppy sales environment, China angst and FX headwinds make NKE vulnerable ahead of...
-
Jefferies & Company Reiterates Buy Rating, $24 PT for DigitalGlobe
Monday, June 25, 2012 - 10:04am | 84In a report published earlier today, Jefferies & Company, Inc. reiterated its Buy rating and $24.00 price target for DigitalGlobe (NYSE: DGI). Jefferies went on to say “On June 22nd after the market close, GeoEye (GEOY, NC, $18.34) filed an 8-K. GeoEye received notification from the NGA of a...
-
UPDATE: Jefferies & Company, Inc. Reiterates Buy Rating, Lowers PT for Abercrombie & Fitch
Monday, June 25, 2012 - 9:59am | 115In a report published earlier today, Jefferies & Company, Inc. reiterated its Buy rating for Abercrombie & Fitch Co. (NYSE: ANF), but lowered its price target from $70.00 to $60.00. Jefferies went on to say “We hosted meetings with mgmt in London and while no big changes came through a few...
-
Jefferies & Company Reiterates Hold Rating, $38 PT for St. Jude Medical
Monday, June 25, 2012 - 9:53am | 113In a report published earlier today, Jefferies & Company, Inc. reiterated its Hold rating and $38.00 for St. Jude Medical, Inc. (NYSE: STJ). Jefferies went on to say “STJ issued a release on Friday with its findings on the Durata failure recently reported in FDA's MAUDE database. After...
-
UPDATE: Jefferies & Company Reiterates Hold Rating, Lowers PT for Impax Laboratories
Monday, June 25, 2012 - 9:49am | 114In a report published earlier today, Jefferies & Company, Inc. reiterated its Hold rating for Impax Laboratories Inc. (NASDAQ: IPXL), but slightly lowered its price target from $21.00 to $20.00. Jefferies went on to say “We've been uneasy with IPXL geared to Gx AXR revenues at risk of...
-
UPDATE: Jefferies & Company Reiterates Buy Rating, Raises PT for Synta Pharmaceuticals
Monday, June 25, 2012 - 9:44am | 115In a report published earlier today, Jefferies & Company, Inc. reiterated its Buy rating for Synta Pharmaceuticals Corporation (NASDAQ: SNTA) and raised its price target from $7.00 to $14.00. Jefferies went on to say “Top-line data from the GALAXY lung cancer Phase 2b interim analysis is...
-
UPDATE: Jefferies & Company Reiterates Buy Rating, Raises PT for Ashland
Monday, June 25, 2012 - 9:35am | 95In a company note published earlier today, Jefferies & Company, Inc. reiterated its Buy rating for Ashland Inc. (NYSE: ASH) and raised its price target from $76.00 to $81.00. Jefferies & Company went on to say “The strong performance in Specialty Ingredients continued in May, supplemented...
-
UPDATE: Jefferies & Company Reiterates Buy Rating, Lowers PT for Kirby Corporation
Monday, June 25, 2012 - 9:15am | 117In a company note published earlier today, Jefferies & Company, Inc. reiterated its Buy rating for Kirby Corporation (NYSE: KEX), but lowered its price target from $77.00 to $70.00. Jefferies & Company went on to say “Kirby has benefitted significantly from strong export demand for...
-
Jefferies & Company Reiterates Buy Rating, $53 PT for Cabot Corporation
Friday, June 22, 2012 - 10:08am | 95In a report published earlier today, Jefferies & Company, Inc. reiterated its Buy rating and $53.00 price target for Cabot Corporation (NYSE: CBT). Jefferies & Company went on to say “Cabot has announced the acquisition of Norit, the leading producer of activated carbon, for $1.1bn, or 12x...